Walleye Trading LLC Argenx Se Call Options Transaction History

Walleye Trading LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$356.95 - $413.29 $4.35 Million - $5.04 Million	-12,200 Reduced 82.43%	2,600 $1.02 Million
Q4 2023 Feb 14, 2024	BUY	$338.91 - $506.01 $4.98 Million - $7.44 Million	14,700 Added 14700.0%	14,800 $5.63 Million
Q3 2023 Nov 14, 2023	SELL	$369.35 - $548.43 $2.73 Million - $4.06 Million	-7,400 Reduced 98.67%	100 $49,000
Q2 2023 Aug 14, 2023	BUY	$360.14 - $422.58 $2.27 Million - $2.66 Million	6,300 Added 525.0%	7,500 $2.92 Million
Q1 2023 May 15, 2023	SELL	$334.23 - $403.65 $768,729 - $928,395	-2,300 Reduced 65.71%	1,200 $447,000
Q4 2022 Feb 14, 2023	BUY	$342.17 - $402.31 $1.2 Million - $1.41 Million	3,500 New	3,500 $1.33 Million
Q1 2022 May 16, 2022	SELL	$254.45 - $351.06 $432,565 - $596,802	-1,700 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$272.01 - $353.03 $462,417 - $600,151	1,700 New	1,700 $595,000

400

30.9M

376K

489K

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.8B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.